SCHEMBL8216947

SCHEMBL8216947

CCOC(=O)C(C)Cc1ccc(Br)cc1CC(C)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
MMP8 P22894 2/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 2/20 0.39
S1PR4 O95977 1/20 0.39
LMNA P02545 1/20 0.39
S1PR1 P21453 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8577196 0.84 CYP1A2 (0.42) SMN1; SMN2MMP8ALDH1A1MEN1KMT2A
SCHEMBL12493852 0.79 KMT2A (0.48) SMN1; SMN2MMP8ALDH1A1MEN1KMT2A
SCHEMBL22122438 0.78 GABRA1 (0.56) MAPTKDM4ERECQLL3MBTL1GABRA1
SCHEMBL2303443 0.78 CA12 (0.44) ALDH1A1TSHR
SCHEMBL8571647 0.78 MMP8 (0.44) SMN1; SMN2MMP8ALDH1A1MEN1KMT2A
SCHEMBL8568021 0.77 CYP3A4 (0.40) SMN1; SMN2MMP8ALDH1A1MAPTMAPK1
SCHEMBL22122374 0.76 LMNA (0.58) SMN1; SMN2ALDH1A1LMNA
SCHEMBL8437061 0.76 EPHX2 (0.49) MMP8ALDH1A1MEN1KMT2AMAPT
SCHEMBL3909041 0.75 ESR1 (0.46) SMN1; SMN2ALDH1A1TSHR
SCHEMBL3903766 0.74 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166002-A Substituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnostics AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-12-26 US disclosed
US-6005010-A CARDIOVASCULAR DISORDERS, ANTIARRHYTHMIA AGENTS AND ANTIISCHEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1999-12-21 US disclosed